Roscovitine: Potent CDK Inhibitor for Cancer Research and Pharmaceutical Development
Discover the power of Roscovitine, a leading CDK inhibitor crucial for advancing cancer research and pharmaceutical development. Explore its potential to halt cell cycle progression and induce apoptosis.
Get a Quote & SampleProduct Core Value
Roscovitine
As a trusted supplier in China, we offer Roscovitine (CAS 186692-46-6), a highly potent and selective inhibitor of cyclin-dependent kinases (CDKs). This compound plays a critical role in cell cycle regulation and is extensively used in cancer research for its ability to induce apoptosis. Our commitment as a manufacturer in China ensures high purity and reliable supply for your research needs.
- Explore the mechanisms of Roscovitine as a leading CDK inhibitor for cancer treatment.
- Understand how Roscovitine facilitates apoptosis induction in various cell lines for pharmaceutical applications.
- Leverage Seliciclib, a key pharmaceutical intermediate, in your drug discovery pipeline.
- Investigate the cell cycle regulation effects of CYC 202 in your studies.
Advantages Offered by the Product
Potent CDK Inhibition
Roscovitine demonstrates sub-micromolar inhibition against key CDKs like CDK1, CDK2, CDK5, CDK7, and CDK9, making it an effective tool for studying cell cycle regulation.
Selective Action
This compound exhibits selectivity for CDKs over many related kinases, ensuring targeted research outcomes and minimizing off-target effects in experimental settings.
Apoptosis Induction
Roscovitine is instrumental in cancer research for its proven ability to induce apoptosis in cancerous cells, a critical step in developing effective cancer therapies.
Key Applications
Cancer Research
Utilize Roscovitine's potent effects on cell cycle arrest and apoptosis for groundbreaking research in oncology and the development of novel anticancer drugs.
Cell Cycle Regulation Studies
Investigate the fundamental processes of cell division and gene expression by employing Roscovitine as a precise modulator of CDK activity.
Drug Discovery & Development
Employ Roscovitine as a critical pharmaceutical intermediate, facilitating the synthesis and testing of new therapeutic agents targeting cell proliferation disorders.
Neurodegenerative Disease Research
Explore the potential of Roscovitine in modulating cellular pathways relevant to neurodegenerative diseases, contributing to future treatment strategies.